Related content

Therapeutic uses of MAbs directed against CD20

By Vose J.M.  

Cytotherapy, Vol. 2, Iss. 6, 2000-06 ,pp. : 455-462

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy

By Jensen Mc   Cooper Ljn   Wu Am   Forman Sj   Raubitschek A  

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 131-138

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cytogenetic evidence of nucleolar dominance in allotetraploid species of Brachypodium

By Idziak Dominika   Hasterok Robert  

Genome, Vol. 51, Iss. 5, 2008-05 ,pp. : 387-391

NRC Research Press

Access to resources Recommend Favorite

Paraoxical relationship between protein content and nucleolar activity in mammalian cardiomyocytes

By Anatskaya Olga V   Vinogradov Alexander E  

Genome, Vol. 47, Iss. 3, 2004-06 ,pp. : 565-578

NRC Research Press

Access to resources Recommend Favorite

In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs

By Derigs H.G.  

Cytotherapy, Vol. 2, Iss. 6, 2000-06 ,pp. : 445-453

Ashgate Publishing Ltd

Access to resources Recommend Favorite